Discontinuation report MYLAN-NITRO SUBLINGUAL SPRAY
Report ID | 227338 |
Drug Identification Number | 02243588 |
Brand name | MYLAN-NITRO SUBLINGUAL SPRAY |
Common or Proper name | NITROGLYCERIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NITROGLYCERIN |
Strength(s) | 0.4MG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | SUBLINGUAL SUBLINGUAL |
Packaging size | 1BT |
ATC code | C01DA |
ATC description | VASODILATORS USED IN CARDIAC DISEASES |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-05-01 |
Remaining supply date | 2024-05-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Discontinued 2024-05-01-The last lots and expiry dates are 0F904/30-Jun-2023 and 0G910/31-Jul-2023 - Reported in shortage ID 181369 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-05-08 | French | Compare |
v1 | 2024-05-08 | English | Compare |
Showing 1 to 2 of 2